Dabigatran versus warfarin in patients with mechanical heart valves: Comment

T D Christensen, Torben Bjerregaard Larsen

Research output: Contribution to journalComment/debateResearchpeer-review

3 Citations (Scopus)

Abstract

It is with great interest we have read the paper by Eikelboom et al. recently published in The New England Journal of Medicine [1]. In this study, dabigatran was compared to warfarin in mechanical heart valve patients. Dabigatran was found to be inferior to warfarin, both in terms of major bleeding and thromboembolic events. We would like to focus on the management in the warfarin group, which we think could have been even further optimized. Firstly, only 30% had aspirin prescribed. It is has been shown that this group of patients benefit from having aspirin in addition to their warfarin treatment, since it reduces the risk of systemic embolism or death [2]. This article is protected by copyright. All rights reserved.
Original languageEnglish
JournalJournal of Thrombosis and Haemostasis
Volume12
Pages (from-to)424-425
Number of pages2
ISSN1538-7933
DOIs
Publication statusPublished - 2014

Bibliographical note

This article is protected by copyright. All rights reserved.

Cite this